The Prognostic Performance of Lung Diffusing Capacity in Preserved Ratio Impaired Spirometry: An Observational Cohort Study

References

• Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax. 2010;65:499–504. doi:10.1136/thx.2009.126052
   PubMed Web of Science ®Google Scholar
• Wijnant SRA, de Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55:1901217. doi:10.1183/13993003.01217-2019
   PubMed Web of Science ®Google Scholar
• Wan ES, Balte P, Schwartz JE, et al. Association between preserved ratio impaired spirometry and clinical outcomes in US adults. JAMA. 2021;326:2287–2298. doi:10.1001/jama.2021.20939
   PubMed Web of Science ®Google Scholar
• Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15:89. doi:10.1186/s12931-014-0089-y
   PubMed Web of Science ®Google Scholar
• Kaise T, Sakihara E, Tamaki K, et al. Prevalence and characteristics of individuals with preserved ratio impaired spirometry (PRISm) and/or impaired lung function in Japan: the OCEAN Study. Int J Chron Obs Pulmon Dis. 2021;16:2665–2675. doi:10.2147/COPD.S322041
   PubMed Web of Science ®Google Scholar
• Washio Y, Sakata S, Fukuyama S, et al. Risks of mortality and airflow limitation in Japanese with preserved ratio impaired spirometry. Am J Respir Crit Care Med. 2022;206(5):563–572. doi:10.1164/rccm.202110-2302OC
   PubMed Web of Science ®Google Scholar
• Guerra S, Carsin A-E, Keidel D, et al. Health-related quality of life and risk factors associated with spirometric restriction. Eur Respir J. 2017;49:1602096. doi:10.1183/13993003.02096-2016
   PubMed Web of Science ®Google Scholar
• Mannino DM, McBurnie MA, Tan W, et al. Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis. 2012;16:1405–1411. doi:10.5588/ijtld.12.0054
   PubMed Web of Science ®Google Scholar
• Nonato NL, Nascimento OA, Padilla RP, et al. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: the PLATINO study. Chron Respir Dis. 2015;12:264–273. doi:10.1177/1479972315588004
   PubMed Web of Science ®Google Scholar
• Schwartz A, Arnold N, Skinner B, et al. Preserved ratio impaired spirometry in a spirometry database. Respir Care. 2021;66:58–65. doi:10.4187/respcare.07712
   PubMed Web of Science ®Google Scholar
• Higbee DH, Granell R, Smith GD, Dodd JW. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022;10(2):149–157. doi:10.1016/S2213-2600(21)00369-6
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease T. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2022 report; 2022. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed October 26, 2022.
   Google Scholar
• Hughes JMB, Pride NB. Examination of the carbon monoxide diffusing capacity (DLCO) in relation to its KCO and VA components. Am J Respir Crit Care Med. 2012;186:132–139. doi:10.1164/rccm.201112-2160CI
   PubMed Web of Science ®Google Scholar
• Marott JL, Ingebrigtsen TS, Çolak Y, Vestbo J, Lange P. Trajectory of preserved ratio impaired spirometry: natural history and long-term prognosis. Am J Respir Crit Care Med. 2021;204:910–920. doi:10.1164/rccm.202102-0517OC
   PubMed Web of Science ®Google Scholar
• Balasubramanian A, Macintyre NR, Henderson RJ, et al. Diffusing capacity of carbon monoxide in assessment of COPD. Chest. 2019;156:1111–1119. doi:10.1016/j.chest.2019.06.035
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis. 1961;84:789–806. doi:10.1164/arrd.1961.84.6.789
   PubMed Web of Science ®Google Scholar
• The examination committee of criteria for “obesity disease” in Japan, Japan Society for the Study of Obesity T. New criteria for “obesity disease” in Japan. Circ J. 2002;66:987–992. doi:10.1253/circj.66.987
   PubMed Web of Science ®Google Scholar
• Clinical pulmonary functions committee of the Japanese Respiratory Society. Guidelines of Respiratory Function Tests: Spirometry, Flow-Volume Curve, Diffusion Capacity of the Lung [in Japanese]. Tokyo: The Japanese Respiratory Society; 2004.
   Google Scholar
• Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242–250. doi:10.1016/j.resinv.2014.03.003
   PubMedGoogle Scholar
• Santos S, Peinado VI, Ramırez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19:632–638. doi:10.1183/09031936.02.00245902
   PubMed Web of Science ®Google Scholar
• Xiao T, Wijnant SRA, Licher S, et al. Lung function impairment and the risk of incident dementia: the Rotterdam Study. J Alzheimer’s Dis. 2021;82:621–630. doi:10.3233/JAD-210162
   PubMed Web of Science ®Google Scholar
• Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Resipir Dis. 1983;128:501–506. doi:10.1164/arrd.1983.128.3.501
   PubMed Web of Science ®Google Scholar
• Lee HY, Kim JW, Lee SH, et al. Lower diffusing capacity with chronic bronchitis predicts higher risk of acute exacerbation in chronic obstructive lung disease. J Thorac Dis. 2016;8:1274–1282. doi:10.21037/jtd.2016.04.66
   PubMed Web of Science ®Google Scholar
• Anami K, Murata S, Nakano H, et al. Physical performance in relation to preserved ratio impaired spirometry: a cross‑sectional study of community‑dwelling older Japanese adults. Sci Rep. 2021;11:17411. doi:10.1038/s41598-021-96830-6
   PubMed Web of Science ®Google Scholar
• Santus P, Radovanovic D, Mascetti S, et al. Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD. Pharmacol Res. 2018;133:160–169. doi:10.1016/j.phrs.2018.05.010
   PubMed Web of Science ®Google Scholar
• Wan ES. The clinical spectrum of PRISm (preserved ratio impaired spirometry). Am J Respir Crit Care Med. 2022;206(5):524–525. doi:10.1164/rccm.202205-0965ED
   PubMed Web of Science ®Google Scholar
• Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:810–816. doi:10.1164/rccm.200602-163OC
   PubMed Web of Science ®Google Scholar
• Washko GR, Hunninghake GM, Fernandez IE, et al.; COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364:897–906. doi:10.1056/NEJMoa1007285
   PubMed Web of Science ®Google Scholar
• Wan ES, Fortis S, Regan EA, et al.; COPDGene Investigators. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene Study. Am J Respir Crit Care Med. 2018;198:1397–1405. doi:10.1164/rccm.201804-0663OC
   PubMed Web of Science ®Google Scholar